Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1525 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	I
2	2	119THCONGRESS
3	3	1
4	4	STSESSION H. R. 1525
5	5	To prohibit the use or declaration of a public health emergency with respect
6	6	to abortion, and for other purposes.
7	7	IN THE HOUSE OF REPRESENTATIVES
8	8	FEBRUARY24, 2025
9	9	Mr. H
10	10	ERNof Oklahoma (for himself, Mr. ADERHOLT, Mr. FEENSTRA, Mr.
11	11	M
12	12	OOLENAAR, Mr. BAIRD, Mr. WEBERof Texas, Mr. WEBSTERof Flor-
13	13	ida, Mr. C
14	14	RENSHAW, Mr. NEWHOUSE, Mr. GREENof Tennessee, Ms.
15	15	B
16	16	OEBERT, Mr. RUTHERFORD, Mr. BOST, Mr. GUEST, Mr. SELF, Mr.
17	17	D
18	18	OWNING, Mrs. MILLERof Illinois, Mr. DAVIDSON, Mr. ROSE, Mr. HAR-
19	19	RIGAN, and Mr. LAMALFA) introduced the following bill; which was re-
20	20	ferred to the Committee on Energy and Commerce
21	21	A BILL
22	22	To prohibit the use or declaration of a public health
23	23	emergency with respect to abortion, and for other purposes.
24	24	Be it enacted by the Senate and House of Representa-1
25	25	tives of the United States of America in Congress assembled, 2
26	26	SECTION 1. SHORT TITLE. 3
27	27	This Act may be cited as the ‘‘Protecting Life from 4
28	28	Chemical Abortions Act’’. 5
29	29	VerDate Sep 11 2014 02:10 Mar 13, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H1525.IH H1525
30	30	kjohnson on DSK7ZCZBW3PROD with $$_JOB 2
31	31	•HR 1525 IH
32	32	SEC. 2. NO DECLARATION OF PUBLIC HEALTH EMERGENCY 1
33	33	WITH RESPECT TO ABORTION. 2
34	34	(a) P
35	35	ROHIBITION.—The Secretary of Health and 3
36	36	Human Services shall not use or declare any public health 4
37	37	emergency under section 319 or 319F–3 of the Public 5
38	38	Health Service Act (42 U.S.C. 247d, 247d–6b) with re-6
39	39	spect to abortion. 7
40	40	(b) T
41	41	ERMINATION OF ANYDECLARATION IN EF-8
42	42	FECT.—Any declaration described in subsection (a) that 9
43	43	is in effect as of the date of enactment of this Act is here-10
44	44	by terminated. 11
45	45	SEC. 3. LIMITATIONS ON ABORTION DRUG. 12
46	46	(a) I
47	47	NGENERAL.—The Secretary of Health and 13
48	48	Human Services, the Commissioner of Food and Drugs, 14
49	49	or any other official within the Department of Health and 15
50	50	Human Services, with respect to the applicable risk eval-16
51	51	uation and mitigation strategy under section 505–1 of the 17
52	52	Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355– 18
53	53	1) relating to abortion drugs— 19
54	54	(1) may not exercise enforcement discretion 20
55	55	with respect to any requirement under such strategy; 21
56	56	and 22
57	57	(2) shall, effective on the date of the enactment 23
58	58	of this Act, reinstate the requirement under such 24
59	59	strategy that abortion drugs be dispensed in only 25
60	60	clinics, medical offices, and hospitals by or under the 26
61	61	VerDate Sep 11 2014 02:10 Mar 13, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H1525.IH H1525
62	62	kjohnson on DSK7ZCZBW3PROD with $$_JOB 3
63	63	•HR 1525 IH
64	64	supervision of a certified health care provider (com-1
65	65	monly referred to as the ‘‘in-person dispensing re-2
66	66	quirement’’). 3
67	67	(b) O
68	68	THERLIMITATIONS.—With respect to the appli-4
69	69	cable risk evaluation and mitigation strategy under section 5
70	70	505–1 of the Federal Food, Drug, and Cosmetic Act (21 6
71	71	U.S.C. 355–1) relating to an abortion drug, the Secretary 7
72	72	of Health and Human Services, the Commissioner of Food 8
73	73	and Drugs, or any other official within the Department 9
74	74	of Health and Human Services— 10
75	75	(1) may not reduce protections (including by 11
76	76	means of any update) in such strategy until every 12
77	77	State submits to the abortion surveillance system of 13
78	78	the Centers for Disease Control and Prevention the 14
79	79	abortion data collected in the aggregate from the 15
80	80	States and entered into a standardized worksheet 16
81	81	that includes questions on the variables specified in 17
82	82	subsection (c); and 18
83	83	(2) may not waive the requirement under such 19
84	84	strategy that such drugs be dispensed in only clinics, 20
85	85	medical offices, and hospitals by or under the super-21
86	86	vision of a certified health care provider (commonly 22
87	87	referred to as the ‘‘in-person dispensing require-23
88	88	ment’’). 24
89	89	VerDate Sep 11 2014 02:10 Mar 13, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H1525.IH H1525
90	90	kjohnson on DSK7ZCZBW3PROD with $$_JOB 4
91	91	•HR 1525 IH
92	92	(c) MANDATORYVARIABLES.—The mandatory vari-1
93	93	ables specified in this subsection shall be treated as man-2
94	94	datory questions for purposes of section 1903(bb) of the 3
95	95	Social Security Act (42 U.S.C. 1396b(bb)) and shall in-4
96	96	clude the following: 5
97	97	(1) Maternal age in years. 6
98	98	(2) Gestational age in completed weeks at the 7
99	99	time of abortion. 8
100	100	(3) Maternal race. 9
101	101	(4) Maternal ethnicity. 10
102	102	(5) Maternal race by ethnicity. 11
103	103	(6) The abortion method type. 12
104	104	(7) Maternal marital status. 13
105	105	(8) Previous pregnancies of the mother, includ-14
106	106	ing the number of previous live births, the number 15
107	107	of previous induced abortions, and the number of 16
108	108	previous spontaneous abortions. 17
109	109	(9) Maternal residence (State or county). 18
110	110	(10) Whether the child survived the abortion. 19
111	111	(11) Congenital anomalies. 20
112	112	(d) D
113	113	EFINITIONS.—In this section: 21
114	114	(1) The term ‘‘abortion’’ means the use or pro-22
115	115	vision of any instrument, medicine, drug, or any 23
116	116	other substance or device— 24
117	117	VerDate Sep 11 2014 02:10 Mar 13, 2025 Jkt 059200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H1525.IH H1525
118	118	kjohnson on DSK7ZCZBW3PROD with $$_JOB 5
119	119	•HR 1525 IH
120	120	(A) to intentionally kill the unborn child of 1
121	121	a woman known to be pregnant; or 2
122	122	(B) to intentionally terminate the preg-3
123	123	nancy of a woman known to be pregnant, with 4
124	124	an intention other than— 5
125	125	(i) after viability to produce a live 6
126	126	birth that, if premature, is medically indi-7
127	127	cated, and to preserve the life and health 8
128	128	of the child born alive; 9
129	129	(ii) to treat an ectopic pregnancy; or 10
130	130	(iii) to remove a dead unborn child. 11
131	131	(2) The term ‘‘abortion drug’’ means any medi-12
132	132	cine, drug, or any other substance or combination of 13
133	133	drugs, medicine, or substances used for an abortion. 14
134	134	(3) The term ‘‘certified health care provider’’ 15
135	135	means a health care provider that has completed a 16
136	136	Prescriber Agreement Form pursuant to the ele-17
137	137	ments for safe use under the applicable risk evalua-18
138	138	tion and mitigation strategy under section 505–1 of 19
139	139	the Federal Food, Drug, and Cosmetic Act (21 20
140	140	U.S.C. 355–1) relating to abortion drugs, under 21
141	141	which the provider agrees to the following: 22
142	142	(A) The provider has the following quali-23
143	143	fications: 24
144	144	VerDate Sep 11 2014 02:10 Mar 13, 2025 Jkt 059200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H1525.IH H1525
145	145	kjohnson on DSK7ZCZBW3PROD with $$_JOB 6
146	146	•HR 1525 IH
147	147	(i) Ability to assess the duration of 1
148	148	pregnancy accurately. 2
149	149	(ii) Ability to diagnose ectopic preg-3
150	150	nancies. 4
151	151	(iii) Ability to provide surgical inter-5
152	152	vention in cases of incomplete abortion or 6
153	153	severe bleeding, or to have made plans to 7
154	154	provide such care through others, and abil-8
155	155	ity to assure patient access to medical fa-9
156	156	cilities equipped to provide blood trans-10
157	157	fusions and resuscitation, if necessary. 11
158	158	(B) The provider will follow the guidelines 12
159	159	for use of mifepristone under the applicable risk 13
160	160	evaluation and mitigation strategy under sec-14
161	161	tion 505–1 of the Federal Food, Drug, and 15
162	162	Cosmetic Act (21 U.S.C. 355–1) relating to 16
163	163	abortion drugs. 17
164	164	(4) The term ‘‘unborn child’’ means an indi-18
165	165	vidual organism of the species homo sapiens, begin-19
166	166	ning at fertilization, until the point of being born 20
167	167	alive as defined in section 8(b) of title 18, United 21
168	168	States Code. 22
169	169	Æ
170	170	VerDate Sep 11 2014 02:10 Mar 13, 2025 Jkt 059200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6301 E:\BILLS\H1525.IH H1525
171	171	kjohnson on DSK7ZCZBW3PROD with $$_JOB